{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:29:00Z","timestamp":1789756140756,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejpb.2022.10.018","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T12:44:27Z","timestamp":1666701867000},"page":"122-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study"],"prefix":"10.1016","volume":"181","author":[{"given":"Hossein","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Kazem Nezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Farmoudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Ebrahimnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Siahposht-Khachaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0005","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2019","journal-title":"J. Neurosurg."},{"issue":"3, Supplement 1","key":"10.1016\/j.ejpb.2022.10.018_b0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.apmr.2007.12.001","article-title":"Congenital and Acquired Brain Injury. 1. Epidemiology, Pathophysiology, Prognostication, Innovative Treatments, and Prevention","volume":"89","author":"Brown","year":"2008","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ejpb.2022.10.018_b0015","doi-asserted-by":"crossref","unstructured":"Y. Li, Y. Li, X. Li, S. Zhang, J. Zhao, X. Zhu, et al., Head injury as a risk factor for dementia and Alzheimer\u2019s disease: a systematic review and meta-analysis of 32 observational studies, PloS One 12(1) (2017) e0169650.","DOI":"10.1371\/journal.pone.0169650"},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.018_b0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","article-title":"Traumatic brain injury","volume":"104","author":"Capizzi","year":"2020","journal-title":"Med. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.018_b0025","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1177\/0271678X17701460","article-title":"Response of the cerebral vasculature following traumatic brain injury","volume":"37","author":"Salehi","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"8","key":"10.1016\/j.ejpb.2022.10.018_b0030","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults","volume":"7","author":"Maas","year":"2008","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1139\/bcb-2016-0160","article-title":"Traumatic brain injury: classification, models, and markers","volume":"96","author":"Najem","year":"2018","journal-title":"Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.10.018_b0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.mpaic.2017.02.008","article-title":"Critical care management of adult traumatic brain injury","volume":"18","author":"Puntis","year":"2017","journal-title":"Anaesth. Intens. Care Med."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury","volume":"99","author":"Werner","year":"2007","journal-title":"BJA: British J. Anaesth."},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nec.2016.06.002","article-title":"Pathophysiology of traumatic brain injury","volume":"27","author":"McGinn","year":"2016","journal-title":"Neurosurg. Clin."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.018_b0055","first-page":"1307","article-title":"The pathophysiology of traumatic brain injury at a glance","volume":"6","author":"Prins","year":"2013","journal-title":"Disease Models Mech."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/jnc.13726","article-title":"Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome","volume":"139","author":"Hill","year":"2016","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/cbin.10915","article-title":"Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism","volume":"42","author":"Ke","year":"2018","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.018_b0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.018_b0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-014-0177-4","article-title":"Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion","volume":"11","author":"Liu","year":"2014","journal-title":"J. Neuroinflam."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.018_b0090","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11892-017-0829-8","article-title":"Metformin: New Preparations and Nonglycemic Benefits","volume":"17","author":"Fujita","year":"2017","journal-title":"Curr. Diab. Rep."},{"issue":"8","key":"10.1016\/j.ejpb.2022.10.018_b0100","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/dc16-2372","article-title":"Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes","volume":"40","author":"Inzucchi","year":"2017","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.ejpb.2022.10.018_b0105","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-5996-5-6","article-title":"Metformin: an old but still the best treatment for type 2 diabetes","volume":"5","author":"Rojas","year":"2013","journal-title":"Diabetol. Metab Syndr."},{"issue":"9","key":"10.1016\/j.ejpb.2022.10.018_b0115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.018_b0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Disease"},{"key":"10.1016\/j.ejpb.2022.10.018_b0130","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bcp.14320","article-title":"Metformin disposition-A 40-year-old mystery","volume":"86","author":"Tucker","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.10.018_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2018.11.013","article-title":"Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice","volume":"140","author":"Garbarino","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.018_b0140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/17425240902939143","article-title":"The potential for nanoparticle-based drug delivery to the brain: overcoming the blood\u2013brain barrier","volume":"6","author":"Barbu","year":"2009","journal-title":"Exp. Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2022.10.018_b0150","first-page":"289","article-title":"Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives","volume":"2","author":"Uner","year":"2007","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.018_b0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: Production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.10.018_b0160","unstructured":"Available from: BioRender.com."},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.018_b0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/02652048.2020.1851789","article-title":"A promising technology for wound healing; in-vitro and in-vivo evaluation of chitosan nano-biocomposite films containing gentamicin","volume":"38","author":"Asgarirad","year":"2021","journal-title":"J. Microencapsul."},{"issue":"10","key":"10.1016\/j.ejpb.2022.10.018_b0170","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3390\/molecules27103135","article-title":"An Experimental Design Approach to Quantitative Expression for Quality Control of a Multicomponent Antidiabetic Formulation by the HILIC Method","volume":"27","author":"Attimarad","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.018_b0175","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11011-020-00594-3","article-title":"Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway","volume":"35","author":"Rahimi","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejpb.2022.10.018_b0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresbull.2021.08.010","article-title":"Morphine attenuates neuroinflammation and blood-brain barrier disruption following traumatic brain injury through the opioidergic system","volume":"176","author":"Rahimi","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/molecules22010182","article-title":"The influence of chitosan cross-linking on the properties of alginate microparticles with metformin hydrochloride\u2014In vitro and in vivo evaluation","volume":"22","author":"Szekalska","year":"2017","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ejpb.2022.10.018_b0190","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/tmi.13587","article-title":"Preparation, characterisation and comparative toxicity of nanopermethrin against Anopheles stephensi and Culex pipiens","volume":"26","author":"Ebrahimnejad","year":"2021","journal-title":"Trop. Med. Int. Health"},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0195","doi-asserted-by":"crossref","first-page":"643","DOI":"10.34172\/apb.2021.073","article-title":"Preparation and evaluation of the antibacterial effect of chitosan nanoparticles containing ginger extract tailored by central composite design","volume":"11","author":"Farmoudeh","year":"2021","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2022.10.018_b0200","doi-asserted-by":"crossref","first-page":"104293","DOI":"10.1016\/j.jmbbm.2020.104293","article-title":"Metformin-loaded nanospheres-laden photocrosslinkable gelatin hydrogel for bone tissue engineering","volume":"116","author":"Qu","year":"2021","journal-title":"J. Mech. Behav. Biomed. Mater."},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/pharmaceutics11040175","article-title":"Modulation of the release of a non-interacting low solubility drug from chitosan pellets using different pellet size, composition and numerical optimization","volume":"11","author":"Partheniadis","year":"2019","journal-title":"Pharmaceutics."},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.018_b0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejpb.2022.10.018_b0215","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2022.10.018_b0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5530\/ijper.53.3.69","article-title":"Development and Application of Lipid Nanotechnology on Infectious Diseases of CNS-Current Scenario","volume":"53","author":"Padhi","year":"2019","journal-title":"Ind. J. Pharm. Educ. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.10.018_b0230","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.colsurfb.2017.10.062","article-title":"Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation","volume":"161","author":"Graverini","year":"2018","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2022.10.018_b0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jiec.2019.01.021","article-title":"Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system","volume":"73","author":"Kim","year":"2019","journal-title":"J. Ind. Eng. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0240","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/03639045.2020.1862172","article-title":"Pharmacokinetics and brain distribution studies of perphenazine-loaded solid lipid nanoparticles","volume":"47","author":"Mohammadi","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"13","key":"10.1016\/j.ejpb.2022.10.018_b0245","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1111\/bph.12655","article-title":"Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy","volume":"171","author":"Jiang","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.10.018_b0250","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood\u2013brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0255","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2013.03.036","article-title":"Metformin induces up-regulation of blood\u2013brain barrier functions by activating AMP-activated protein kinase in rat brain microvascular endothelial cells","volume":"433","author":"Takata","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.ejpb.2022.10.018_b0260","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1080\/02699052.2020.1807055","article-title":"The integrated functions of the cardiac autonomic and vestibular\/oculomotor systems in adolescents following severe traumatic brain injury and typically developing controls","volume":"34","author":"Sorek","year":"2020","journal-title":"Brain Inj."},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.018_b0265","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neubiorev.2004.06.002","article-title":"Motor and cognitive function evaluation following experimental traumatic brain injury","volume":"28","author":"Fujimoto","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.018_b0270","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4103\/1673-5374.300330","article-title":"Motor tract reorganization after acute central nervous system injury: a translational perspective","volume":"16","author":"Takase","year":"2021","journal-title":"Neural Regener. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02005-x","article-title":"Cellular infiltration in traumatic brain injury","volume":"17","author":"Alam","year":"2020","journal-title":"J. Neuroinflam."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0280","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1200-y","article-title":"Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury","volume":"15","author":"Rowe","year":"2018","journal-title":"J. Neuroinflam."},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.018_b0285","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/biom10071017","article-title":"The regulatory role of IL-10 in neurodegenerative diseases","volume":"10","author":"Porro","year":"2020","journal-title":"Biomolecules."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-97441-x","article-title":"Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism","volume":"11","author":"Postler","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2022.10.018_b0295","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainresbull.2018.04.008","article-title":"Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-\u03baB and MAPK signaling pathway","volume":"140","author":"Tao","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.018_b0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12031-007-9002-1","article-title":"Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons","volume":"34","author":"El-Mir","year":"2008","journal-title":"J. Mol. Neurosci."},{"issue":"16","key":"10.1016\/j.ejpb.2022.10.018_b0305","first-page":"2387","article-title":"Modulation of the oxidative stress by metformin in the cerebrum of rats exposed to global cerebral ischemia and ischemia\/reperfusion","volume":"18","author":"Abd-Elsameea","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:50:15Z","timestamp":1760547015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":61,"alternative-id":["S0939641122002442"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.10.018","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}